ALS Limited (ASX:ALQ) acquired Reliance Clinical Testing Services, Inc. on November 29, 2022.

ALS Limited (ASX:ALQ) completed the acquisition of Reliance Clinical Testing Services, Inc. for AUD 17.2 million on November 29, 2022. The cash consideration is AUD 17.2 million and cash acquired of target is AUD 3.2 million.